[Summary] Committed to developing innovative drugs in therapeutic areas such as
Ascentage Pharma is a biopharmaceutical company rooted in China with a global vision. It was listed on the Main Board of the Hong Kong Stock Exchange on October 28, 2019, under the stock code 6855.HK.
As one of the earliest companies in China to begin research and development of original innovative drugs, Ascentage Pharma is dedicated to developing innovative drugs in therapeutic areas such as oncology, hepatitis B, and aging-related diseases, and consistently adheres to a patient-centered global innovation strategy. All of the company's pipeline projects are original innovative drugs with novel chemical structures, aimed at addressing the "untreatable and unmet" clinical needs of patients in China and around the world, filling domestic gaps and benefiting patients globally.
At present, Ascentage Pharma has built an international talent team with strong experience in original innovative drug R&D and clinical development, as well as a commercialization team with extensive experience in hematologic oncology. In the future, the company will further accelerate the global clinical development and commercialization of its pipeline products, enabling more patients to benefit sooner.
What does Suzhou Ascentage Pharma Co., Ltd. require? Who is Suzhou Ascentage Pharma Co., Ltd. hiring? recruitment: 医疗卫生/美容保健类占比最多占42.2%,其次是销售类占35.8%. What education can get in at ? 本科占比最多占60.3%,其次是硕士占21.6%. High education required at ? 硕士占21.6%,博士占10.8%. Work experience required at ? 5-10年占比最多占41.8%,其次是3-5年占36.6%. Where are the job locations at ? 苏州占比最多占22.4%,其次是上海占19%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows